Cargando…
Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417994/ https://www.ncbi.nlm.nih.gov/pubmed/35790817 http://dx.doi.org/10.1038/s41375-022-01626-w |
| _version_ | 1784776848767451136 |
|---|---|
| author | Möker, Paula zur Stadt, Udo Zimmermann, Martin Alawi, Malik Mueller, Stephanie Finger, Jasmin Knörr, Fabian Riquelme, Amambay Oschlies, Ilske Klapper, Wolfram Bradtke, Jutta Burkhardt, Birgit Woessmann, Wilhelm Damm-Welk, Christine |
| author_facet | Möker, Paula zur Stadt, Udo Zimmermann, Martin Alawi, Malik Mueller, Stephanie Finger, Jasmin Knörr, Fabian Riquelme, Amambay Oschlies, Ilske Klapper, Wolfram Bradtke, Jutta Burkhardt, Birgit Woessmann, Wilhelm Damm-Welk, Christine |
| author_sort | Möker, Paula |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9417994 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94179942022-08-28 Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia Möker, Paula zur Stadt, Udo Zimmermann, Martin Alawi, Malik Mueller, Stephanie Finger, Jasmin Knörr, Fabian Riquelme, Amambay Oschlies, Ilske Klapper, Wolfram Bradtke, Jutta Burkhardt, Birgit Woessmann, Wilhelm Damm-Welk, Christine Leukemia Letter Nature Publishing Group UK 2022-07-05 2022 /pmc/articles/PMC9417994/ /pubmed/35790817 http://dx.doi.org/10.1038/s41375-022-01626-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Möker, Paula zur Stadt, Udo Zimmermann, Martin Alawi, Malik Mueller, Stephanie Finger, Jasmin Knörr, Fabian Riquelme, Amambay Oschlies, Ilske Klapper, Wolfram Bradtke, Jutta Burkhardt, Birgit Woessmann, Wilhelm Damm-Welk, Christine Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia |
| title | Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia |
| title_full | Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia |
| title_fullStr | Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia |
| title_full_unstemmed | Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia |
| title_short | Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia |
| title_sort | characterization of ig-myc-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric burkitt-lymphoma and -leukemia |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417994/ https://www.ncbi.nlm.nih.gov/pubmed/35790817 http://dx.doi.org/10.1038/s41375-022-01626-w |
| work_keys_str_mv | AT mokerpaula characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT zurstadtudo characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT zimmermannmartin characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT alawimalik characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT muellerstephanie characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT fingerjasmin characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT knorrfabian characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT riquelmeamambay characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT oschliesilske characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT klapperwolfram characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT bradtkejutta characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT burkhardtbirgit characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT woessmannwilhelm characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia AT dammwelkchristine characterizationofigmycbreakpointsandtheirapplicationforquantitativeminimaldiseasemonitoringinhighriskpediatricburkittlymphomaandleukemia |